4//SEC Filing
Knight Jeff E. 4
Accession 0000950170-24-131064
CIK 0001658247other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:30 PM ET
Size
4.9 KB
Accession
0000950170-24-131064
Insider Transaction Report
Form 4
Knight Jeff E.
Chief Operating Officer
Transactions
- Sale
Common Stock
2024-11-22$56.52/sh−501$28,317→ 51,653 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Includes 501 shares acquired under the Issuer's Employee Stock Purchase Plan.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001881007
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 4:30 PM ET
- Size
- 4.9 KB